call 1800 257 600 email [email protected]

Teratoma

Teratomas are a type of germ-cell tumour that contains different types of bodily tissue, such as hair, bone, muscle and teeth. They contain elements from three embryonic germ layers; the endoderm (the innermost layer that forms the respiratory and gastrointestinal tracts), the mesoderm (the middle layer that forms the circulatory and lymphatic system, bone, cartilage, muscles and various organs) and the ectoderm (the outermost layer that forms the nervous system, skin, and sensory organs such as the eyes, ears and nose).

Germ cell tumours are a rare group of neoplasms that arise from primordial germ cells – the cells responsible for developing into reproductive cells (gametes) such as ovum and sperm. These tumours typically originate in the gonads, which are the organs that produce gametes (ovaries in females and the testicles in males). These tumours are referred to as gonadal germ cell tumours. In some cases, germ cells can migrate to other parts of the body during early embryonic development, leading to tumour formation outside of the gonads later in life. These are known as extragonadal germ cell tumours, and are most commonly found in the brain, mediastinum, retroperitoneum, or sacrococcygeal region.

Teratomas are broadly classified into three different categories: mature teratomas, immature teratomas and teratomas with somatic type malignancy. Mature teratomas are generally benign, and contain cells that look similar to healthy tissue but contain bodily tissue that shouldn’t be present within the brain (such as skin, hair, muscle, bone, etc.). Immature teratomas can be malignant, and contain cells that cells look similar to those found in a fetus, while also containing components not generally found in the brain. Teratomas with somatic type malignancy are malignant, and occur when a teratoma develops a non-germ cell component, such as a sarcoma.

Teratomas are more common in females, with the average age at presentation varying by subtype. However, anyone can develop this disease.

Types of Teratomas

Teratomas can be classified by their location within the body.

Gonadal Teratomas

Gonadal teratomas are more common, and develop in either the ovaries or testicles.

Ovarian Teratomas

Ovarian teratomas are a common type of germ-cell tumour that generally affects females in the reproductive age range. Most of these tumours are mature, benign, and discovered incidentally. Immature ovarian teratomas are less common, and tend to affect females under 20 years old. Immature ovarian teratomas can be malignant, but can have a good prognosis when caught early.

Testicular Teratomas

Testicular teratomas are a type of germ-cell tumour that occur most often in males under the age of 40. In prepubertal males, teratomas are usually benign and composed of mature tissues. However, in post pubertal males, testicular teratomas are considered malignant regardless of histological maturity due to their potential for local invasion and metastasis. While malignant testicular teratomas can be aggressive, they can have a good prognosis when found early.

Extragonadal Teratomas

Extragonadal teratomas are much less common than gonadal teratomas, and develop in areas other than the gonads.

Mediastinal Teratomas

Mediastinal teratomas are the most common type of extra-gonadal germ-cell tumour that develops in the mediastinum, most commonly the anterior mediastinum. Mature mediastinal teratomas are generally diagnosed between the ages of 20-40, often found incidentally, and tend to be benign and slow growing. Immature teratomas are more likely to occur in infants and children, and are almost always found in males. When immature teratomas are malignant, they can be aggressive, but can have a good prognosis when found early.

Sacrococcygeal Teratomas

Sacrococcygeal teratomas are the most common type of germ-cell tumours in fetuses, newborns and infants. These tumours arise at the base of the spine in an area known as the sacrococcygeal region. Most sacrococcygeal teratomas are mature and benign, especially when diagnosed in the neonatal period, and may be detected during pregnancy on an ultrasound or present as a visible mass at birth. Immature sacrococcygeal teratomas are less common, tend to occur in older infants and children, and have a higher risk of malignancy.

Sacrococcygeal teratomas can also be classified based on location:

  • Type I: the most common subtype; tumour develops almost completely outside of the body.
  • Type II: tumour develops outside of the body but extends into the pelvis.
  • Type III: tumour develops outside of the body, but extends through the pelvis and into the abdomen.
  • Type IV: tumour develops entirely inside the pelvis.

Sacrococcygeal teratomas can have a good prognosis when found early.

Rare types of Teratoma

These types of teratoma are considered to be very rare:

  • Congenital cervical teratoma.
  • Intracranial teratoma.
  • Retroperitoneal teratoma.
  • Spinal cord teratoma.

Treatment

If a teratoma is detected, it will be staged and graded based on size, metastasis, and how the cancer cells look under the microscope. Staging and grading help your doctors determine the best treatment for you.

FIGO Staging System – Ovarian Teratomas

Ovarian cancers can be staged using the Federation of Gynaecology and Obstetrics (FIGO) system from stage I to IV:

  • Stage I: cancer cells are confined to one or both ovaries only. This stage is also known as early-stage cancer.
  • Stage II: cancer cells have grown deeper into nearby organs in the pelvis, such as the uterus, fallopian tubes, bladder and/or bowel. This is also known as localised cancer.
  • Stage III: the cancer has become larger and has spread beyond the pelvis into the lining of the abdomen (peritoneum). Lymph nodes are also often affected. This is also known as advanced or metastatic cancer.
  • Stage IV: the cancer has spread to more distant organs, such as the lungs or the liver. This is also known as advanced or metastatic cancer.

TMN Staging System

All other teratomas can be staged using the TNM staging system:

  • T (tumour) indicates the size and depth of the tumour.
  • N (node) indicates whether the cancer has spread to nearby lymph nodes.
  • M (metastasis) indicates whether the cancer has spread to other parts of the body.

This system can also be used in combination with a numerical value, from stage 0-IV:

  • Stage 0: this stage describes cancer cells in the place of origin (or ‘in situ’) that have not spread to nearby tissue.
  • Stage I: cancer cells have begun to spread to nearby tissue. It is not deeply embedded into nearby tissue and had not spread to lymph nodes. This stage is also known as early-stage cancer.
  • Stage II: cancer cells have grown deeper into nearby tissue. Lymph nodes may or may not be affected. This is also known as localised cancer.
  • Stage III: the cancer has become larger and has grown deeper into nearby tissue. Lymph nodes are generally affected at this stage. This is also known as localised cancer.
  • Stage IV: the cancer has spread to other tissues and organs in the body. This is also known as advanced or metastatic cancer.

Cancers can also be graded based on the rate of growth and how likely they are to spread:

  • Grade I: cancer cells present as slightly abnormal and are usually slow growing. This is also known as a low-grade tumour.
  • Grade II: cancer cells present as abnormal and grow faster than grade-I tumours. This is also known as an intermediate-grade tumour.
  • Grade III: cancer cells present as very abnormal and grow quickly. This is also known as a high-grade tumour.

Once your tumour has been staged and graded, your doctor may recommend genetic testing, which analyses your tumour DNA and can help determine which treatment has the greatest chance of success. They will then discuss the most appropriate treatment option for you.

Treatment Options

Treatment is dependent on several factors, including location, age, stage of disease and overall health.

Treatment options for teratomas may include:

  • Surgery to remove as much of the tumour as possible – will vary based on tumour location.
  • Chemotherapy.
  • Ablation therapy.
  • Clinical trials.
  • Palliative care.

Gonadal Teratoma Treatment and Fertility

Treatment for ovarian and testicular teratomas may make it difficult to conceive a child. If fertility is important to you, discuss your options with your doctor and a fertility specialist prior to the commencement of treatment.

Risk factors

Because of how rare teratomas are, there has been limited research done into the risk factors of this disease. However, a link has been found between the development of mediastinal germ cell tumours and males with the genetic disorder Klinefelter syndrome.

Symptoms

The symptoms of embryonal carcinoma will vary based on location.

Symptoms of Ovarian Teratoma

Symptoms of ovarian teratoma may include:

  • Pelvic pain.
  • Abdominal pain.
  • A palpable pelvic mass.
  • Ovarian torsion (rare).

Symptoms of Testicular Teratoma

Symptoms of testicular teratoma may include:

  • A painless mass in the testicle(s).
  • Changes in testicular size and/or shape.
  • A feeling of heaviness and/or unevenness in the scrotum.
  • Pain or discomfort in the testicle(s) and/or scrotum (less common).

Symptoms of Mediastinal Teratoma

Symptoms of mediastinal teratoma may include:

  • Dyspnea.
  • Chest pain.
  • Persistent cough.
  • Haemoptysis.
  • Superior vena cava syndrome, which has its own set of symptoms:
  • Coughing.
  • Dyspnea.
  • Swelling of the face, neck, and/or upper arms.

Symptoms of Sacrococcygeal Teratoma

Symptoms of sacrococcygeal teratoma may include:

  • Large mass at the base of the spine.
  • Kidney or bladder enlargement or blockage (rare).
  • Hydrops (accumulation of fluid in a fetuses body, causing swelling).

Not everyone with the symptoms above will have cancer, but see your general practitioner (GP) if you are concerned.

Diagnosis

If your doctor suspects you have a teratoma, they may order the following tests to confirm the diagnosis and refer you to a specialist for treatment:

  • Physical examination.
  • Endocrine studies.
  • Blood tests.
  • Imaging tests, potentially including:
    • Ultrasound.
    • MRI (magnetic resonance imaging).
    • CT (computed tomography) scan.
    • PET (positron emission tomography) scan.
    • Chest X-ray (mediastinal teratomas).
  • Exploratory surgery.
  • Biopsy (where possible).

Exploratory Surgery

After conducting the previously mentioned diagnostic tests, your doctor may strongly suspect that you have testicular or ovarian cancer. In most cases, a diagnosis can be confirmed after a biopsy, where a section of tissue is removed and analysed for cancer cells. However, doctors avoid conducting a biopsy in patients who have suspected testicular and ovarian cancer as there is a small risk that making an incision in the scrotum or ovary could cause cancer cells to spread.  As such, the only way to confirm the diagnosis safely is to remove the affected gonad.

Once the gonad has been removed, it will be sent to a laboratory and analysed for cancer cells.

References

Keep up with Rare Cancers Australia

Inside Rare is a monthly newsletter that shares the latest news, events and stories connecting the rare community.